KOLKATA, October 07, 2021: For the first time in Eastern India, doctors at Apollo Multispecialty Hospital gave a new lease of life to an unborn by interstitial laser therapy using Diode laser. In Interstitial Diode Laser Therapy a fine needle is inserted into the mother’s womb to release some laser beams into the sick twin which gets terminated in the process to save its healthier co-twin. The procedure is conducted with the continuous support of ultrasound.Due to more people opting to become parents at a later age and hence the increase of IVF there has been a significant increase of twin babies around the world. Currently, one in fifty pregnancies have twin babies and twin pregnancies are always high-risk pregnancies. Among all twin pregnancies, about 66% are dichorionic (babies form from 2 separate eggs and sperms and have separate compartments with separate blood flow inside the uterus) and 33% are monochorionic (babies form from 1 egg and 1 sperm and have a common compartment with single blood flow inside the uterus).In the case of monochorionic twin pregnancy, there is a high chance of cross (selective) intrauterine growth restriction called Twin-to-twin-transfusion syndrome (TTTS), which is the most important cause of prenatal death of twins. The syndrome typically occurs in the second trimester in about 10-15% of monochorionic twin pregnancies and one of the babies don’t grow as expected and compared to the other. This happens as sharing the same placenta causes blood flow imbalance amongst the twins, where one foetus becomes the so-called donor twin and the other the recipient.If untreated, perinatal mortality is unavoidable as one baby dies due to lack of nutrition and the other due to overnutrition. Secondly, if there is any clot or cardiac dysfunction in the weaker baby due to lack of nourishment, the clot or cardiac issue gets transferred to the healthy baby as well through the common placenta causing the death of the healthy baby within 72 hours of the weaker baby’s death inside the foetus. In this case, the mother was detected with the issue at 14 weeks of pregnancy, when saving both the babies by ensuring proper growth inside the womb was impossible.Interstitial Laser Therapy is the only procedure that can save at least one baby out of the two. In a single treatment procedure, with help of ultrasound in order to see the foetus and placenta, the technique separates the connection of the vessels between the two babies. As a result of this, the weaker donor baby stops receiving nutrition while the healthy baby keeps growing inside the foetus.Dr Jayanta Kr Gupta, Director & HOD Obstetrics & Gynaecology, Apollo Multispecialty Hospitals, Kolkata said, “It’s indeed a tough decision for parents to let go of one of the twins before birth, but this is the only way to save the other baby or else both the babies can’t live. We here at Apollo for the very first time in Eastern India did the procedure of Interstitial Laser Therapy so that we can at least save one of the twins. The treatment was applied in a case of Twin-to-twin-transfusion syndrome (TTTS), which is unique to identical twins, who by nature get nutrition supplied by a single placenta. And we hope to perform on more pregnant women with Twin-to-twin-transfusion syndrome so that they don’t lose their babies due to this condition of intrauterine growth restriction. For this, early detection through regular check-ups including USG is critical during pregnancy.”About Apollo Hospitals Enterprise Ltd. (AHEL)It was in 1983, that Dr. Prathap C. Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai.Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 71 Hospitals, 3,300 Pharmacies, over 90 Primary Care Clinics and 150 diagnostic centres, 110 plus Telemedicine Centres, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research, Apollo Hospitals has been at the forefront of new medical advancements with the most recent investment being the commissioning of South East Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C. Reddy, was conferred with the prestigious Padma Vibhushan in 2010.For 35 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.For more information:Amitava Chakraborty | amitava_c@apollohospitals.com | 9804000201Sumantika Choudhury | sumantika.choudhury@adfactorspr.com| 9830056185

Fatty liver disease is rapidly becoming a major health concern in India. Studies suggest fatty liver affects a significant portion of the Indian population, with estimates ranging from 10% to 30%. India’s growing rates of obesity, diabetes, and unhealthy lifestyles contribute heavily to fatty liver. Often symptomless in the early stages, NAFLD can progress to serious complications like liver cirrhosis and liver failure if left unaddressed. Promoting healthy lifestyles with proper diet and exercise to manage weight and improve overall health.Apollo Hospitals, has inaugurated its latest endeavour, the Apollo Fatty Liver Clinic at Liver Diseases and Transplantation Institute, Apollo Hospitals, Chennai. This cutting-edge facility introduces the game-changing diagnostic marvel, ‘FibroScan Expert 630,’ poised to revolutionize liver care and tackle Non-Alcoholic Fatty Liver Disease (NAFLD) head-on. The Fatty Liver Clinic was inaugurated by the esteemed actor, Mr Prasanth Thiagarajan, marking a significant stride in Apollo Hospitals’ unwavering commitment to pioneering medical care.Apollo Fatty Liver Clinic features world’s most advanced diagnostic tools and offers newer pharmacological treatments for management of fatty liver.The key highlight, FibroScan Expert 630, is a state-of-the-art diagnostic tool that goes beyond the ordinary. This advanced equipment, enables spleen stiffness measurement, an embedded ultrasound guidance system, and precise risk stratification for advanced chronic liver disease patients, and it is a beacon of hope for optimised patient care.Dr. N Murugan, Senior Consultant Hepatologist, Apollo Hospitals, Chennai, said, “Fatty liver disease is increasing in our country due to changing lifestyle, sedentary habits and increasing stress; approximately 35 to 40% of our adult population may have fatty liver. Around a quarter of these patients may go on to develop advanced liver disease. Technology like the Fibroscan 630 helps us to accurately assess early signs of liver damage non-invasively, and treatment can then be given to prevent progression of liver disease in these patients”Mr. Prashanth said, “I extend my heartfelt wishes to Apollo Hospitals on the inauguration of the Advanced Liver Disease and Transplantation Institute. Recognizing the growing prevalence of liver diseases among people today, initiatives like this aimed at early detection and immediate intervention are pivotal in mitigating the risk of these conditions escalating into serious illnesses. Apollo’s proactive focus on prevention by treating it in the early stage itself is truly commendable and reflects their dedication to addressing this pressing health concern.”To celebrate this monumental launch, Apollo Hospitals is extending a gesture of care to the community. The first 75 individuals will receive complimentary check-ups at the hospital, offering an exclusive opportunity to experience advanced liver health assessments and consultations with leading specialists.The Liver Disease and Transplantation Institute, specialising in the diagnosis and treatment of liver conditions, with a unique focus on advancing care for NAFLD patients, embodies Apollo Hospitals’ mission to provide comprehensive and specialised healthcare services. This initiative is not just about treating ailments; it’s about ushering in a new era of wellness and pushing the boundaries of healthcare excellence.

Hyderabad, October 2021: The Apollo Hospitals Group, Asia’s foremost integrated healthcare services provider, today announced the launch of Varian’s TrueBeam radiotherapy system with Velocity, an intelligent software solution for interventional oncology at Apollo Cancer Institute, Apollo Health City campus, Hyderabad. The versatile TrueBeam is capable of treating a wide range of cancers with high accuracy and precision allowing oncologists or cancer specialists to treat many types of complex cancer cases. Patients also benefit due to the comfort, accuracy, and speed permitted by the TrueBeam system. The addition of the specialized software, Velocity, organizes patient data and makes it available in one place to help clinicians make more informed treatment decisions. Chief Guest Dr. (Smt.) Tamilisai Soundararajan, Hon’ble Governor of Telangana and Hon’ble Lt. Governor of Puducherry; inaugurated, Telangana’s first and only Truebeam STx with velocity, offering precision radiation and better clinical outcomes; at Apollo Cancer Centre, Jubilee Hills; today. Speaking on the occasion, she said, Apollo is known for offering the best care available in the world. It’s a moment of pride for Apollo Health City to have this state of the art TrueBeam radiotherapy system with Velocity, it also a moment of pride for the entire state of Telangana to have the latest and the only TrueBeam radiotherapy. The evolution of radiation therapy has enabled to deliver differential dose within the target volume, ranging from zero to 100% dose. Innovation in imaging for patient on treatment couch has improved the accuracy of radiation delivery, which is called the image guided radiation therapy, where the target is visualized every day prior to treatment, enabling the highest possible comfort. Today with the latest TrueBeam machine we have the capacity to treat cancer with all the very best of technology put together in 6D robotic couch and CG Image guidance for best accuracy in treatment. It delivers highly precise intensity modulated radiotherapy in the shortest possible time where the patient gets to go to home in 1 to 3 days with the least possible side effects. All these go a long way to get the patient the best possible treatment with minimal side effects. Cancer has been a rising threat with alarming statistics, in 2020 we saw around 13.25 lakh new cases of cancer in India, with 8.5 lakh deaths due to cancer. We must be cautious and concerned, it is estimated that by 2025, there will be 12% rise in cancer cases. It is a matter of concern that in 1990 there were 54 cancer patients per lakh population in Telangana and the incidence has since risen to 75 per lakh in less than three decades time. TrueBeam enables to access advanced care without the need for patients to go abroad, she added.Ms Shobana Kamineni, Executive Vice Chairperson Apollo Hospitals Groups said, the launch of the TrueBeam LINAC with Velocity is another milestone in Apollo Hospitals’ battle against cancer, one of the dreaded non-communicable diseases that in just the last year has seen over 13 lakh new cases and over 8.5 lakh deaths. With TrueBeam LINAC, our patients can rest assured that they will receive the most advanced radiotherapy techniques with the added benefits of a high degree of accuracy and a shorter treatment time for a successful treatment. In line with our move to an increased degree of digital healthcare, the Velocity software will provide our oncologists with the tools for data-driven clinical decision making that will help to reduce the mortality and morbidity from cancer. Apollo’s mission from day one has been to bring the best of care to every individual and to make it affordable. Many of the technologies we offer in our hospitals are the latest in the world available at a fraction of the treatment cost abroad. Not just Indians, many people from across the globe come to Apollo to find cure. There is no family in the world off late with someone developing Cancer, many have experienced the pain, which is evident from the statistics of 1 in 8 women in India will have breast cancer, the recurrence of cancers has seen a steep 50% increase from 1990 to 2020. Whatever resources with hospitals like ours with most proficient doctors with unparallel knowledge and skills are the warriors of today, who will be able to fight and make sure as Chairman Dr Prathap C. Reddy always says, cancer is no more a death knell.TrueBeam has been used for treating patients in over 90 countries and every year around 1.5 million patients receiving treatment on a TrueBeam linear accelerator (LINAC). TrueBeam is Varian’s most advanced LINAC, with the system incorporating many technical innovations that intuitively and dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. TrueBeam uses intelligent automation that not just simplifies the workflow, but also guides the specialists step-by-step through each radiotherapy treatment.The Velocity software organizes patient data and makes it available in one place, allowing the oncologist to access and compile treatment and imaging data from diverse systems for a comprehensive view of a patient’s diagnostic imaging and treatment history. This leads to more informed treatment decisions by facilitating close collaboration between physicians, oncologists, medical physicists, and others on the team. It also helps in cases of retreatment for recurrence or metastases.Dr Vijay Anand Reddy, Director Oncology Apollo Cancer Center Apollo Hospitals, Hyderabad said, “The TrueBeam platform with Velocity provides us with the tools to manage and treat our patients optimally. Many times, a patient has multiple treatments over a long period or even after a gap especially if metastatic lesions occur months or even years later. It is here that the Velocity software allows the treating doctors to understand a patient’s full clinical history and reach a judicious decision about the way forward. It puts more power into the hands of the oncologist with a comprehensive view of a patient’s diagnostic imaging and treatment history, regardless of where they were treated or what technology was used. Velocity makes it possible to manage the entire cancer treatment journey from diagnosis to completion of treatment.”About Apollo Hospitals:It was in 1983, that Dr. Prathap C Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai.Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals and 4100 pharmacies, over 120 Primary Care clinics and 650 Diagnostic centres, 700 plus Teleclinics, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials. The most recent investment being the commissioning of South East Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010.For 37 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.

Dr. Prathap C Reddy dedicates AICVD tool for prediction and prevention of heart disease to the physicians of the nation.National, September 27, 2021: Apollo Hospitals today announced the national launch of an AI (artificial intelligence) tool to predict risk of cardiovascular disease. The Apollo AI-powered Cardiovascular Disease Risk tool will help healthcare providers to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference. The cardiac risk scoring tool is remarkable for the speed in processing data and its accuracy at predicting the probability of a patient developing coronary disease. Using the tool, physicians will be enabled to deliver proactive, pre-emptive and preventive care for at-risk individuals, improving lives while mitigating future pressure on healthcare systems. On the occasion, Apollo Hospitals also announced that it has found pride of place in the Best Specialized Hospitals 2022 ranking released by Newsweek, the premier international news magazine and website. The ranking in partnership with global research firm Statista ranks the world’s best specialized hospitals and features the top 250 hospitals for cardiology and oncology and the top 150 for paediatrics among ten specialities. The Apollo Heart Centre at Apollo Hospitals, Chennai makes it to the list of Best Specialized Hospitals 2022 – Cardiology with a global rank of 126 and ranks No. 1 among the five Indian hospitals in the list.Also, in the Best Specialized Hospitals 2022 – Oncology, two hospitals from the Apollo Hospitals Group make it to the list with Apollo Cancer Centres at Apollo Speciality Cancer Hospital, Chennai and Apollo Hospitals, Chennai ranked at 228 and 239 respectively. The two hospitals are among just four Indian hospitals that are in list for Oncology. In the Paediatric speciality, Apollo Children’s Hospital, Chennai ranked at 103 globally and one among just five Indian hospitals that are part of the Best Specialized Hospitals 2022 – Paediatrics ranking.Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “The nation’s economy is intricately linked to the health of the people with non-communicable diseases (NCDs) leading to loss of productivity with a consequent impact on national income. While estimates suggest that NCDs account for an economic burden in the range of 5% to 10% of GDP, it is the chronic nature of NCDs, and their projected increase in prevalence, that will result in a growing economic impact if not addressed in time. Among the rising burden of NCDs, cardiovascular diseases (CVDs) figure at the top. Cardiovascular disease is the leading cause of death in the Asia Pacific, and it’s a problem that will only intensify as our populations continue to age. It’s also a problem that healthcare providers struggle to diagnose early enough to make a real difference.“While some predictive tools do exist to help physicians understand the probability of their patients developing heart disease, most of these are based on Western data sets and don’t take regional risk variations into account. This impacts their accuracy when applied in an Indian context. The Apollo AI-powered Cardiovascular Disease Risk tool will change that and put the knowledge and the means to predict and prevent heart disease in the physician’s hands. Available till now only to Apollo’s physicians, it is a proud moment for us to dedicate this AI tool to all physicians in the country.”Speaking on the Newsweek recognition, Dr. Prathap C Reddy added, “This global recognition is testament to the specialty healthcare of international standards provided at Apollo Hospitals with outcomes matching those of the world’s best hospitals. Apollo Hospitals, with some of the world’s finest and brightest medical experts, has been the pioneer in bringing ground-breaking healthcare technologies to India to deliver best in class clinical results.”The team at Apollo Hospitals collected more than ten years of data relating to 400,000 individuals across the country. Then, they used Microsoft Azure to turn that anonymized data into actionable insights that data scientists and clinicians could use to train machine learning models. The tool has been validated using data from the Maastricht Study, a long-term cohort health study in the Maastricht region and from the Heart+Vascular Center at Maastricht University Medical Center, Netherlands.Ms. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said, “The AI tool to predict and prevent heart disease is the fruition of many years of research and development and stands testament to Apollo Hospitals’ technological prowess. Apollo’s AI-powered Cardiovascular Disease Risk Score is specifically for use in the Indian population, so physicians can better predict the risk of cardiac disease in their patients. The tool is built on algorithms based on ten years of anonymized data relating to around 400,000 individuals across the country collected by the team at Apollo Hospitals.“The tool has also been validated internationally using federated learning through Microsoft Azure Platform. Doctors across the Apollo network have been leveraging this AI-powered tool for three years to predict risk of cardiovascular disease and drive preventive cardiac care across the country. With this launch of the AI tool to predict risk of heart disease, we will be able to help achieve the World Health Organization’s goal of reducing the risk of premature mortality from non-communicable diseases, including CVDs, by 25% by 2025.”The AI-powered tool delivers a more accurate CVD risk score using algorithms specifically for the Indian population and helps in developing standardised care regimens. Developed using a combination of applied AI and clinical expertise on a large sample of retrospective data on health checks and coronary events, the tool delivers a risk score that takes into account all contributing factors including lifestyle attributes such as diet, tobacco & smoking preferences and physical activity as well as psychological stress and anxiety as reflected via rate of respiration, and hypertension. The risk is categorized into High, Moderate and Minimal. The tool also gives insights on the risk contributors that can be modified to improve the score. This enables physicians to give a more holistic advice to their patients with specific insights for lifestyle modification.

The Legend of the Year Cardiology & Cardiothoracic Surgery Dr. A.G.K. Gokhale Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. P.C. Rath Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. Sunil Kapoor Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. Vijay Dixit Apollo HospitalsThe Legend of the Year ENT Dr. E.C. Vinaya Kumar Apollo HospitalsThe Rising Star General Medicine Dr. Rajiv Paul Apollo HospitalsThe Legend of the Year Neurology & Neurosurgery Dr. Alok Ranjan Apollo HospitalsThe Legend of the Year Obstetrics & Gynecology Dr. Rooma Sinha Apollo HospitalsThe Rising Star Oncology Dr. T.P.S Bhandari Apollo HospitalsThe Legend of the Year Oncology Dr. Vijay Anand Reddy Apollo HospitalsThe Legend of the Year Ophthalmology Dr. Rajesh Fogla Apollo HospitalsThe Legend of the Year Orthopedics Dr. Jairamchander Pingle Apollo HospitalsThe Legend of the Year Urology Dr. K. Subrahmanyam Apollo Hospitals   

Apollo Hospitals launched a super specialty hospital at Sheshadripuram in Bangalore. Present at the inaugural ceremony were Shri. Dinesh Gundurao, Hon’ble Minister of State for Food, Civil Supply and Consumer Affairs, Dr. Prathap C Reddy , Chairman & Founder, Apollo Hospitals, Ms. Suneeta Reddy, Managing Director, Apollo Hospitals, Gen. Dr. Naresh Parmar, CEO – Apollo Hospitals, Karnataka Region and Mr Ravindra Pai, COO, Apollo Hospitals, Sheshadripuram, amongst other dignitaries.The 200 bedded facility developed in 2 acres , is the fourth hospital in the state of Karnataka in addition to the ones existing at Bannerghatta Road & Jayanagar in Bangalore and in Mysore. Apollo Hospitals continues to keep up with its commitment towards bringing quality healthcare closer and accessible to all. “We started about 33 years back with our first hospital at Chennai and the journey so far has been remarkable. Apollo Hospitals has been established to address the rapid rise of NCDs that are affecting the population of Bangalore”, said Dr Prathap C Reddy, Chairman& Founder, Apollo Hospitals, “It is disheartening to see that people continue to suffer from disorders like Heart Attacks, Epilepsy, Stroke and many others diseases despite the fact that timely diagnosis and proper treatment can prevent or cure any disease”, he further added.Apollo Hospital, Sheshadripuram , is well-equipped with latest infrastructure, state of the art technology and a team of specialists to address and cater to the rising need of attention towards non communicable diseases which are on the rise in the state. “Particularly in Bangalore, we see about 1200 cases coming to us every month on an average between the age group of 30-40 years. The primary focus of the Apollo Hospital, Sheshadripuram , would be to tackle NCDs that have witnessed a rapid increase in the number of cases especially in the recent years”, said Lt. Gen. Dr Naresh Parmar, CEO – Apollo Hospitals, Karnataka Region.Apollo Hospital, Sheshadripuram, would focus on five specialties Cardiac Sciences, Neurosciences, Orthopaedics, Medical & Surgical Gastroenterology & General and Laparoscopic Surgery led by a team of experts with combined experience of over 100 years.Apollo Hospitals Launched A Super Specialty Hospital At Sheshadripuram In Bangalore

Hyderabad, September 23rd, 2021 : A team of Cardiologists led by Dr Karunakar Rapolu, Consultant Cardiologist, Apollo Hospitals; performed a complex interventional procedure using Impella, IVL and OCT; on an extremely critical 61 year old patient. The patient had 90% blockage due to high calcium deposit in the Left Main Vessel, which was jeopardising the blood supply to already severely weakened heart. A preliminary medical evaluation found him unsuitable for a bypass surgery, due to his past history of Coronary Artery Disease and having undergone an angioplasty three years ago. The Team had to swiftly explore for options to restore blood circulation before his condition deteriorated further and became fatal. The patient Mr Ravinder Reddy, a retired police official, presented with excruciating chest pain and symptoms of severely restricted blood flow to the heart due to calcification of the largest coronary artery, the Left Anterior Descending Artery (LAD). The LAD became narrow progressively since his previous angioplasty and manifested in the form of a massive heart attack. At the Hospital the patient was quickly wheeled into the Cath lab for an angiogram to assess the extent of heart damage. However, he developed dysfunction of the Left ventricular heart chamber, on the table, leading to sparse supply of blood to the vital organs and potential damage of those if not acted instantaneously. This episode further complicated his condition and the team had to resort to administering diuretics to rid excess fluids from the patient’s body and vasodilators to open the blocked vessels.His perilous condition ruled out any scope of performing the risk laden bypass surgery. The team narrowed down on the most apt option considering his delicate condition, of performing a CHIP Intervention (Complex High-risk Indicated Procedure) along with an Impella Heart Pump. CHIP Intervention is a highly critical procedure performed for immediate restoring of blood supply in the circulation system, while Impella replicates the work done by Left Ventricle, helps suck the oxygenated blood from the Left Ventricle and pumps it to the circulatory system. Using the infrared light guidance from OCT (Optical Coherence Tomography), the extent of occlusion was assessed and those high resolution images facilitated clearing of the blockage with precision. Intravascular lithotripsy (IVL) Balloon was used to crack the impregnable calcification of the blockage. IVL deploys acoustic pressure waves to break the calcium deposits. A stenting was done of the Left Main Coronary Artery using DK crush technique for the best outcome.During the course of the procedure the patient suffered 7-8 episodes of “Ventriculo arterial uncoupling” while inflating the balloon to clear occlusion, where the left ventricle ceased pumping the blood. Impella got into action and ensured uninterrupted supply of blood. The patient would have crashed during the procedure if Impella was not availed. The procedure took four and half hours, patient was moved out of ICU after 24 hours of the procedure. He has since recovered and was discharged on the 4th day of admission. He needs to take regular medicines and to follow healthy life style habits like regular exercises and diet management. Patient tolerated the procedure very well because of Impella heart pump which was working continuously to protect him, Oct guided the team to be precise, while IVL helped in the success of the procedure, says Dr Karunakar Rapolu.About Apollo Hospitals:It was in 1983, that Dr. Prathap C Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai.Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals and 4100 pharmacies, over 120 Primary Care clinics and 650 Diagnostic centres, 700 plus Teleclinics, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials. The most recent investment being the commissioning of South East Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010.For 37 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.

 Actor Sai Dharam Tej’s Health Bulletin Updates14 Sept, 2021Mr. Sai Dharma Tej is stable and is in the weaning mode of respiratory support. The vital parameters and the biomedical tests are satisfactory. The expert team of Doctors will continue to observe his clinical condition further.13 Sept, 2021Mr. Sai Dharma Tej condition is stable. He is on the weaning mode of ventilation and showing a good progress . The vital parameters and the biomedical tests are satisfactory.12 Sept, 2021Mr. Sai Dharma Tej condition is stable and improving . The procedure for collar bone fracture has successfully been completed by our multidisciplinary team of experts.He will continue to be under observation11th Sept, 2021Mr. Sai Dharam Tej was brought to Apollo Hospitals, Jubilee Hill, following a road traffic accidentHe was intubated and put on assisted respiration at the nearest hospital and later shifted here. As of now he is medically stable. There are no major injuries to brain, spine and major organs, based on preliminary investigations. He sustained soft tissue injuries and a collar bone fracture.He is being closely monitored and further evaluation will be bone, over the next 24 hours. There is no need for any immediate surgical intervention.The next medical update will be released at 9am tomorrow morning11th Sept, 2021Mr. Sai Dharam Tej is stable and all major organs are functioning well.He will continue to be on assisted respiration in ICU for controlled close monitoring and additional investigations will be performed during the day.

Apollo Proton Cancer Centre (APCC) is poised to revolutionize global healthcare. In collaboration with Belgium-based IBA, a global leader in proton therapy, APCC, in its series of training programs on PBT, recently completed imparting training to its first batch of eminent doctors from Indonesia and Vietnam. Through this initiative, India becomes the first country in Southeast Asia to host a specialized proton beam therapy training program for international oncologists.Being the first Indian cancer centre to launch the training program in PBT, it marks a new chapter in collaborative cancer treatment and solidifies its position as a front-runner in knowledge sharing and advancing global cancer care. Similar training programs are in the pipeline for oncologists from Kazakhstan, Malaysia, Slovenia and Philippines.Advantages of PBT training at APCCOver 1400 patients have been successfully treated. Patients from over 147 countries access Apollo Hospitals. Practicum-an intensive clinical and academic event with experts in PBT from six continents. Over 350 National and International Virtual tumor board discussions Successful implementation of organ based practice for all modalities Pro Connect–a platform for our clinical network with international oncologists to discuss advanced and complicated cancers.Proton Beam Therapy has emerged as a highly precise and effective radiation treatment for various cancers, offering targeted tumor treatment while minimizing damage to surrounding healthy tissues. So far, APCC has treated over 1400 patients, the youngest being a 10-month-old boy, and has achieved remarkable clinical outcomes, elevating the quality of life of cancer warriors.H. E. Mr. Didier Vanderhasselt, Ambassador of Belgium to India, honored the event as a chief guest, and said, “From the historic beginnings of diplomatic relations between Belgium and India to the present day, where pioneering advancements in healthcare stand testament to our enduring collaboration. Belgium is proud to support initiatives that drive innovation and excellence in cancer care.“In a powerful statement marking the occasion, Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Enterprises Limited, emphasized the transformative impact of their collaboration with IBA. “This alliance is a testament to our dedication to forging global healthcare partnerships. By uniting our strengths and expertise, we significantly enhance our collective capacity to tackle cancer worldwide. The training program is a landmark event in our partnership, facilitating an unhindered exchange of knowledge across frontiers. It equips Oncologists globally with cutting-edge insights into Proton Beam Therapy. This collaboration is a clear manifestation of our unified vision to democratize access to innovative treatments worldwide, heralding a new era in healthcare where advanced solutions are within reach for everyone.”Dr. Nguyen Thi Minh Hue, Radiation Oncologist, Cho Ray Hospital, Vietnam, said, “Participating in the specialized training program at Apollo Proton Cancer Centre is an exceptional opportunity to enhance our skills and knowledge in Proton Beam Therapy. We look forward to acquiring valuable skills and knowledge during the training program which will enable us to better serve our patients and contribute to the development of cancer care in Vietnam.”Dr. Febryono Basuki Raharjo, HOD-Radiation Oncology, Dharmais National Cancer Center, Indonesia, said, “Being part of the proton beam therapy training initiative at APCC is a game-changer for Indonesian oncologists. India stands as a beacon of world-class expertise in cancer care, and the Centre exemplifies this commitment to excellence. Through this training, we aim to bring the benefits of PBT to more patients in Indonesia and beyond, ultimately improving cancer care outcomes in our region.”The event was further graced by the below dignitaries Mr Dadang Hidayat, Minister Counsellor, Embassy of the Republic of Indonesia, New Delhi, Mr. Basir Ahmed, Deputy Chief of Mission, from the Indian Ambassador in Indonesia, and Mr. N Ashok Kumar, Adviser, (Industry & Engineering), Embassy of India to Belgium who joined virtually.The training program at APCC is meticulously designed to enhance the skills and knowledge of oncologists from diverse backgrounds, fostering collaboration and knowledge exchange to drive further innovation in cancer treatment. Through this initiative, APCC and IBA aim to empower doctors with the expertise necessary to deliver superior cancer care to patients across the region.

 Hyderabad, July 2021: The three day ‘TCT India South Asia 2021′ – India’s premier Interventional Cardiology Conference – organized by FACTS Foundation – a non-profit organization of Cardiologists and Cardiac Surgeons, committed to newer research, innovation, education, and training; in association with Apollo Hospitals and Cardiovascular Research Foundation, will be hosted virtually from July 29th, 2021. Mr Y Subramanyam, Regional CEO, Apollo Hospitals, Hyderabad; Dr A. Sreenivas Kumar, Founder Director, FACTS Foundation; & Sr. Consultant Cardiologist & Director Cardiology and Clinical Research, Apollo Hospitals, Hyderabad; Dr Ravindra Babu, Asst. Director of Medical Sciences, Apollo Hospitals, and Dr Rama Krishna, Cardiologist, Apollo Hospitals; announced the details of the Virtual conference at a press conference, today at Apollo Hospitals. This event is being successfully conducted for the 12th year now in 2021, the maiden Conference was held in 2010.Dr A. Sreenivas Kumar speaking on the occasion said, this is now the largest Conference of Interventional Cardiologists, with delegates from India, Bangladesh, Nepal, Myanmar, Mauritius, Sri Lanka, and more countries are attending it. Several special techniques to deal with cardiac problems which hitherto needed cardiac surgery can be done today by interventional cardiology, through the minor aperture, saving the patient from trauma, morbidity, and mortality. In the past when arteries were totally blocked, surgery was mandatory, now there are special techniques to clear the blocked arteries, several such new techniques will be demonstrated and deliberated in this conference. It’s difficult to get so much knowledge from the most eminent specialists, this platform brings all of them together and makes the knowledge available in a nutshell to the delegates. The live streaming of the Conference is happening at all the PVR cinemas across the country, the big screens help delegates to get a clear picture of the procedures and techniques and enable a better understanding of what is being demonstrated. This conference has special sessions devoted to Covid Cardiology addressed by eminent specialists from across the world, who extensively dealt with Covid related cardiology problems. The conference overall will address and educate the delegates on the latest techniques beneficial to the patients in terms of speedy recovery and being inexpensive to the possible extent.Mr Y Subramanyam said, more than 5000 delegates registered for this conference making it one of the biggest Interventional Cardiology Conferences. Cardiologists from across the globe are immensely excited about the knowledge in store this Conference is going to impart.The faculty at the Conference comprises the world’s eminent Interventional Cardiologists and several leading Indian cardiologists. The International faculty of World-Renowned Interventional Cardiologists includes Dr Martin B. Leon, Director, New York-Presbyterian Hospital; Dr Gregg W. Stone, Director, New York-Presbyterian Hospital; Dr Dimitrios Karmpaliotis, Interventional Cardiology Specialist, New York, NY; Dr. Gary Mintz, Senior Medical Advisor, Cardiovascular Research Foundation, New York; Dr Susheel Kodali, Director, New York-Presbyterian Hospital; Dr Ajay J. Kirtane, Director, New York-Presbyterian Hospital; Dr Ziad A. Ali, cardiologist, New York; Dr Duane Pinto, Interventional Cardiology, Harvard Medical School; Dr Sanjog Kalra, Interventional Cardiologist, Columbia University Medical Center Education, New York; Dr Miroslaw Ferenc, University Heart Center Freiburg – Germany and Dr Ramesh Daggubati, Director Structural Heart Interventions, West Virginia University, WV, among others.The Conference will have 24 Live cases to be streamed live to 4K projections across 9 Hubs, a first-of-its-kind initiative in India, thereby multiplying the reach of the knowledge being imparted. Over 5000 delegates from across the country and abroad are expected to participate, making it one of the largest Interventional Cardiology conferences. The latest techniques used in performing complicated procedures will be telecast live from leading cardiac centers abroad and across India. The eminent faculty will have the comfort to demonstrate the techniques from the Cath labs they function from, enabling them to be at their proficient best from familiar environs. Live Cases will be transmitted from the USA, Germany & UK and 20 Centers across India, some of the centers participating in the live transmission are Apollo Health City, Hyderabad; Apollo Hospitals, Chennai; Apollo Hospitals, Bengaluru; Apollo Hospitals, Mumbai; Medanta, New Delhi, etc.The Conference will deliberate and demonstrate the latest advances in interventional cardiology, including Transcatheter aortic valve replacement (TAVR), Railway Catheter & other newer Radial Access Devices & techniques, LAA Occlusion Procedures, Pharmacology for Interventionists, Antiplatelet therapy, How FFR and IVUS/OCT optimize patient outcomes, Mitra Clip, Transseptal Technique; etc., through live workshops and also throw light on topics like Role of Telemedicine & AI in tough Covid times, “India has got Talent Sessions” – Young & Dynamic Interventional Cardiologists across India and Asia can showcase their talent.EDUCATION WITH LIVE CASES IN ENTERTAINMENT SPACES (EDUTAINMENT) in TOUGH COVID TIMES….....

More than 250 school children, teachers and gym instructors received training in Basic Life Support and First-Aid today at Apollo Institute of Medical Sciences and Research (AIMSR), Hyderabad. The training in Cardio-Pulmonary Resuscitation (CPR) was done by a team of Life-Support Instructors from Department of Emergency Medicine, Apollo Hyderabad, as a part of the National Assembly on Pediatric Emergency Medicine (NAPEM) conference. NAPEM 2017 is being conducted by the Society for Trauma and Emergency Pediatrics (STEP) in collaboration with the Society for Emergency Medicine India (SEMI), the Indian Academy of Pediatrics (IAP) and Apollo Hospitals. The conference is hosted with the intent of raising the awareness and standard of care for pediatric emergencies in all hospitals.Dr. Imron Subhan, Head of the Apollo Hyderabad Emergency Department, said “In an emergency, bystanders who witness an accident should provide first-aid and quickly get the victim to the hospital. If they hesitate or delay the transportation, then even emergency doctors cannot do much for a patient. Every family should have at least one person trained in Basic Life Support and First-Aid skills”. Dr. Dinakar who was the lead instructor said “CPR and First- Aid training should be a part of the every school curriculum along with other subjects like History, Geography and Science”.More advanced training in pediatric emergency care was conducted in the state-of-art Simulation Training Center at Apollo, where more than 160 emergency doctors and pediatric specialists practised management of medical emergencies and trauma situations on simulated robotic manikins.Dr. Imron, who is also the organizing secretary for the conference said “We have to make all emergency departments safer for children, and better take care of sick and injured pediatric patients. Children with emergency conditions are bound to land up both, in pediatric, as well as adult emergency departments. All emergency doctors have to be ready to resuscitate and stabilize infants and children, and this can happen only with good training by using simulated scenarios on manikins.Faculty for this training included both National and International experts in pediatric emergency medicine, and from the Society for Trauma & Emergency Pediatrics, and the Society for Emergency Medicine India.Call Us Now 08069991035   

Hyderabad, July 2021: A team of doctors led by renowned Cardiothoracic Surgeon and Padmasri awardee Dr. Alla Gopala Krishna Gokhale performed a rare, combined Heart and Lung transplant on 20th July 2021 to save a terminally ill twenty-five-year-old woman, Ms Labdhi Jain. The recipient was unfortunately born with congenital heart disease with a hole in her heart known as a ventricular septal defect and an abnormal connection between her great arteries (Aorto-pulmonary window). Over the years, the congenital defect led to further deterioration in her health condition with increased lung pressures and leakage of heart valves. She was surviving on oxygen support at home for the last two-and-half years. Of late, she was admitted at various hospitals several times for heart failure. The transplant team at Apollo Hospitals, Hyderabad, on evaluation found her to be in an advanced stage of heart failure coupled with increased lung pressures. The team prescribed combined Heart and Lung transplantation to save her life. She was registered under the State Government’s Jeevandan Cadaver Transplantation program and was waiting for a suitable donor. The team faced unique challenges in this case. The recipient at the time of listing for transplant weighed only 30 kgs. Getting a suitable organ which was of appropriate in size for her was complex, as her heart cavity was small. She was helplessly waiting for a suitable organ for a prolonged period of over two and half years, with the hope of finding a small-sized organ diminishing by the day.The cadaver heart and lung obtained from an eighteen-year-old girl, pronounced brain dead due to intracranial bleeding and thrombosis, aptly suited her requirement. Despite the immense sorrow of losing their child, the donor’s family displayed exemplary courage and benevolence and gave consent to harvest their braindead daughter’s organs. This humanitarian gesture on behalf of the grief-stricken loved ones brought joy back in the life of another family.The recipient recovered well after surgery; her weight has improved to 38 kgs. She is being discharged from the hospital, freed from the burden of heart and lung disease, to enjoy life the way she deserves, and to overcome any obstacles that come her way with confident strides and a happy heart.About Apollo HospitalsIt was in 1983, that Dr. Prathap C Reddy made a pioneering endeavor by launching India’s first corporate hospital – Apollo Hospitals in Chennai. Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals, 3800 pharmacies, over 120 Primary Care clinics, and 650 Diagnostic centers, 700 plus Teleclinics, over 15 medical education centers, and a Research Foundation with a focus on global Clinical Trials. The most recent investment is the commissioning of Southeast Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honor, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For 38 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.